Description
This product utilizes cytokine-Induced T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1CS222-20). We employs the Retrovirus (CMV-GFP-TFIIB-XbaI) vector components and the SynExpress system of the exons RNA Editing/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1CS222-20
Species Reactivity
Human
Cell Source
Cytokine-Induced T cells
Sensor Gene
GFP
Promoter
CMV
Effector Gene
TFIIB
Insertion Sites
XbaI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.98
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.